0013Y0 — MSBIO. Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for MSBIO., fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Revenue
Total Revenue	14,823	17,973	23,787
Cost of Revenue
Gross Profit	9,028	11,660	15,786
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	10,147	11,929	15,256
Operating Profit	4,676	6,044	8,531
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	4,884	6,145	8,595
Provision for Income Taxes
Net Income After Taxes	4,277	5,320	7,288
Net Income Before Extraordinary Items
Net Income	4,277	5,320	7,288
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,277	5,320	7,288
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	157	194	269
Dividends per Share